Julian E. Fuchs
Lensfield Road
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Understanding the Role of H-Bonds in the Stability of Molecular Glue-Induced Ternary Complexes.
Journal: Journal of chemical information and modeling
Published: January 23, 2026
Discovery of Macrocyclic Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors that Demonstrate Potent Cellular Efficacy and In Vivo Activity in a Mouse Solid Tumor Xenograft Model.
Journal: Journal of medicinal chemistry
Published: August 27, 2025
Discovery of BI-2493, a Pan-KRAS Inhibitor Showing In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: July 25, 2025
Probing Protein-Ligand Methyl-π Interaction Geometries through Chemical Shift Measurements of Selectively Labeled Methyl Groups.
Journal: Journal of medicinal chemistry
Published: July 29, 2024
Ligandability assessment of the C-terminal Rel-homology domain of NFAT1.
Journal: Archiv der Pharmazie
Published: November 08, 2023
Ligand 1 H NMR Chemical Shifts as Accurate Reporters for Protein-Ligand Binding Interfaces in Solution.
Journal: Chemphyschem : a European journal of chemical physics and physical chemistry
Published: September 06, 2023
Drugit: crowd-sourcing molecular design of non-peptidic VHL binders.
Journal: Nature communications
Published: August 16, 2023
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo.
Journal: Nature communications
Published: March 02, 2022
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling.
Journal: Nature cancer
Published: July 27, 2021
A Step toward NRF2-DNA Interaction Inhibitors by Fragment-Based NMR Methods.
Journal: ChemMedChem
Published: June 24, 2021
Last Updated: 09/26/2026